<html>
<body>
<H2>
Evidence That Light Modulates Protein Nitration in Rat Retina <A NAME="RFN2"></A><SUP><A HREF="#FN2">*</A></SUP>
</H2>

<STRONG>
</NOBR><NOBR>Masaru Miyagi<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<A HREF="#COR1"><IMG SRC="/math/link//sect.gif" ALT="&#167;" BORDER="0"></A></SUP></NOBR>, 
<NOBR>Hirokazu Sakaguchi<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Ruth M. Darrow<SUP>&#182;</SUP></NOBR>, 
<NOBR>Lin Yan<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Karen A. West<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Kulwant S. Aulak<SUP>||</SUP></NOBR>, 
<NOBR>Dennis J. Stuehr<SUP>||</SUP></NOBR>, 
<NOBR>Joe G. Hollyfield<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Daniel T. Organisciak<SUP>&#182;</SUP></NOBR> and 
<NOBR>John W. Crabb<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,||</SUP><SUP>,<A HREF="#COR2">**</A></SUP></NOBR>
</STRONG><P>
<FONT SIZE=-1>
<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP> Cole Eye Institute<BR>
<SUP>||</SUP> Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195<BR>
<SUP>&#182;</SUP> Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio 45435
</FONT><P>



<P>
<A NAME="ABS"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
ABSTRACT
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>ABSTRACT</FONT><BR>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>


As part of ongoing efforts to better understand the role of<SUP> </SUP>protein oxidative modifications in retinal pathology, protein<SUP> </SUP>nitration in retina has been compared between rats exposed to<SUP> </SUP>damaging light or maintained in the dark. In the course of the<SUP> </SUP>research, Western methodology for detecting nitrotyrosine-containing<SUP> </SUP>proteins has been improved by incorporating chemical reduction<SUP> </SUP>of nitrotyrosine to aminotyrosine, allowing specific and nonspecific<SUP> </SUP>nitrotyrosine immunoreactivity to be distinguished. A liquid<SUP> </SUP>chromatography MS/MS detection strategy was used that selects<SUP> </SUP>all possible nitrotyrosine peptides for MS/MS based on knowing<SUP> </SUP>the protein identity. Quantitative liquid chromatography MS/MS<SUP> </SUP>analyses with tetranitromethane-modified albumin demonstrated<SUP> </SUP>the approach capable of identifying sites of tyrosine nitration<SUP> </SUP>with detection limits of 4&#150;33 fmol. Using two-dimensional<SUP> </SUP>gel electrophoresis, Western detection, and mass spectrometric<SUP> </SUP>analyses, several different nitrotyrosine-immunoreactive proteins<SUP> </SUP>were identified in light-exposed rat retina compared with those<SUP> </SUP>maintained in the dark. Immunocytochemical analyses of retina<SUP> </SUP>revealed that rats reared in darkness exhibited more nitrotyrosine<SUP> </SUP>immunoreactivity in the photoreceptor outer segments. After<SUP> </SUP>intense light exposure, immunoreactivity decreased in the outer<SUP> </SUP>segments and increased in the photoreceptor inner segments and<SUP> </SUP>retinal pigment epithelium. These results suggest that light<SUP> </SUP>modulates retinal protein nitration <I>in vivo</I> and that nitration<SUP> </SUP>may participate in the biochemical sequela leading to light-induced<SUP> </SUP>photoreceptor cell death. Furthermore, the identification of<SUP> </SUP>nitrotyrosine-containing proteins from rats maintained in the<SUP> </SUP>dark, under non-pathological conditions, provides the first<SUP> </SUP>evidence of a possible role for protein nitration in normal<SUP> </SUP>retinal physiology.<SUP> </SUP><P>

<HR NOSHADE SIZE=1 WIDTH="50%" ALIGN="CENTER">


Nitration of tyrosine is one of several protein modifications<SUP> </SUP>that can occur as a result of oxidative stress (<A HREF="#R1">1</A>). A number<SUP> </SUP>of inflammatory and neurodegenerative disorders have been associated<SUP> </SUP>with tyrosine nitration including ocular inflammation, retinal<SUP> </SUP>ischemia, lung infection, cancer, Parkinson&#146;s disease,<SUP> </SUP>Alzheimer&#146;s disease, and Huntington&#146;s disease (<A HREF="#R2">2</A>).<SUP> </SUP>The abundancy of this protein modification is low, perhaps less<SUP> </SUP>than 1 in 10<SUP>6</SUP> tyrosine (<A HREF="#R3">3</A>), and identification of all <I>in vivo</I><SUP> </SUP>protein nitration targets have utilized antibodies directed<SUP> </SUP>against nitrotyrosine (<A HREF="#R4">4</A>). The only successful identification<SUP> </SUP>of <I>in vivo</I> sites of tyrosine nitration to date has been achieved<SUP> </SUP>with histone H2B from mouse tumors, a relatively abundant protein<SUP> </SUP>that may accumulate more nitrotyrosine than the average cellular<SUP> </SUP>protein because of greater stability and lower turnover (<A HREF="#R5">5</A>).<SUP> </SUP>Previously we used a combination of immunological detection<SUP> </SUP>and MALDI-TOF <A NAME="RFN1"></A><SUP><A HREF="#FN1">1</A></SUP> MS to identify proteins nitrated on tyrosine<SUP> </SUP>during inflammatory challenge (<A HREF="#R4">4</A>) and now focus on a possible<SUP> </SUP>link between protein nitration and retinal light damage. Partial<SUP> </SUP>protection from retinal light damage has been observed in rats<SUP> </SUP>treated with <I>N</I>-nitroarginine methyl ester (<A HREF="#R6">6</A>), an inhibitor<SUP> </SUP>of nitric-oxide synthase. Because nitric-oxide synthase provides<SUP> </SUP>the <I>in vivo</I> precursor for nitrating agents, nitration may play<SUP> </SUP>a role in light-induced retinal degeneration.<SUP> </SUP><P>

Retinal damage from intense visible light was reported first<SUP> </SUP>in 1966 (<A HREF="#R7">7</A>) yet the molecular mechanisms remain poorly understood.<SUP> </SUP>Light-induced photoreceptor cell degeneration appears to involve<SUP> </SUP>both apoptosis and necrosis (<A HREF="#R8">8</A>&#150;<A HREF="#R10">10</A>) via a process initiated<SUP> </SUP>by oxidative stress, because antioxidants such as ascorbate<SUP> </SUP>and dimethylthiourea provide protection (<A HREF="#R8">8</A>, <A HREF="#R10">10</A>). Damaging light<SUP> </SUP>is thought to produce reactive oxygen species; however the identity<SUP> </SUP>of such species and the pathways of oxidative damage remain<SUP> </SUP>unknown (<A HREF="#R10">10</A>). The similarity in the action spectrum of retinal<SUP> </SUP>light damage and the absorption spectrum of rhodopsin (<IMG SRC="/math/sim.gif" ALT="~" BORDER="0">500 nm<SUP> </SUP>maximum) has lead to the hypothesis that injury may be initiated<SUP> </SUP>by rhodopsin bleaching (<A HREF="#R7">7</A>, <A HREF="#R11">11</A>). Additional evidence supports<SUP> </SUP>the involvement of retinoids in the process. Blue light induces<SUP> </SUP>apoptosis in cultured retinal pigment epithelial cells in a<SUP> </SUP>manner related directly to the content of pyridinium bisretinoid,<SUP> </SUP><I>i.e.</I> lipofuscin component A2E (<A HREF="#R12">12</A>). <I>In vitro</I>, light induces<SUP> </SUP>aggregation of the photoreceptor-specific protein ABCR in the<SUP> </SUP>presence of all-<I>trans</I>-retinal (<A HREF="#R13">13</A>). Dietary vitamin A-depleted<SUP> </SUP>rats (<A HREF="#R14">14</A>), as well as animals with impaired visual cycle retinoid<SUP> </SUP>processing proteins such as CRALBP (<A HREF="#R15">15</A>), RPE65 (<A HREF="#R16">16</A>), and RDH5<SUP> </SUP>(<A HREF="#R17">17</A>), appear to be more resistant to light damage than normal<SUP> </SUP>control animals. However age, diet, genetics, and environmental<SUP> </SUP>light history all influence the extent and type of retinal injury<SUP> </SUP>from light exposure (<A HREF="#R8">8</A>).<SUP> </SUP><P>

The purpose of this study was to improve methods for characterizing<SUP> </SUP>protein nitration and to investigate whether protein nitration<SUP> </SUP>is a mediator in photoreceptor light damage. An improved 2D<SUP> </SUP>gel Western method for detecting nitrated proteins is described,<SUP> </SUP>and a quantitative baseline is established for LC MS/MS determination<SUP> </SUP>of sites of tyrosine nitration. We have also surveyed the nitroproteome<SUP> </SUP>of retina from rats exposed to intense light or maintained in<SUP> </SUP>the dark. The results indicate that the distribution and identity<SUP> </SUP>of nitrotyrosine-containing proteins within the cell layers<SUP> </SUP>of the retina changes with light exposure.<SUP> </SUP><P>

<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
EXPERIMENTAL PROCEDURES
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>EXPERIMENTAL PROCEDURES</FONT><BR>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG><EM>Animal Procedures and Retinal Preparations&#151;</EM></STRONG><BR>

Albino male Sprague-Dawley rats (Harlan Inc., Indianapolis,<SUP> </SUP>IN) were received at 21 days of age and maintained in darkness<SUP> </SUP>until use. The dark environment was interrupted with dim red<SUP> </SUP>illumination about 30 min per day during routine animal care.<SUP> </SUP>The rats were fed a standard rat chow (Teklad, Madison, WI)<SUP> </SUP>and given water <I>ad libitum</I>. Rats maintained in a dark environment<SUP> </SUP>for 2&#150;4 months were exposed to intense (1500 lux) green<SUP> </SUP>light (490&#150;580 nm) for 3 h and sacrificed immediately<SUP> </SUP>following light treatment under dim red illumination in a chamber<SUP> </SUP>with a CO<SUB>2</SUB>-saturated atmosphere. All procedures involving rats<SUP> </SUP>followed the protocols outlined in the ARVO Statement for the<SUP> </SUP>Use of Animals in Ophthalmic and Vision Research. Four animals<SUP> </SUP>were used for 2D gel Western analyses of retinal proteins, and<SUP> </SUP>eight animals were used for immunocytochemistry. Retinas were<SUP> </SUP>excised from rats within 2 min of death as described by Delmelle<SUP> </SUP><I>et al.</I> (<A HREF="#R18">18</A>), rinsed in PBS, and frozen in liquid nitrogen. Photoreceptor<SUP> </SUP>rod outer segments (ROS) were isolated from retinas using a<SUP> </SUP>discontinuous sucrose gradient technique as described by Organisciak<SUP> </SUP><I>et al.</I> (<A HREF="#R19">19</A>) and stored at -80&#176;C until use.<SUP> </SUP><P>

<STRONG><EM>Gel Electrophoresis&#151;</EM></STRONG><BR>

Each frozen retina was homogenized in 50 &#181;l of isoelectric<SUP> </SUP>focusing (IEF) solvent B (7 <FONT SIZE=-2>M</FONT> urea, 2 <FONT SIZE=-2>M</FONT> thiourea, 4% CHAPS,<SUP> </SUP>0.5% Triton X-100, 2% carrier ampholite, pH 3&#150;10, 1% dithiothreitol)<SUP> </SUP>using a disposable pestle at 4&#176;C. The homogenate was centrifuged<SUP> </SUP>at 14,000 rpm/min (Eppendorf table tap centrifuge 5415C) for<SUP> </SUP>30 min, and the supernatant was collected. Photoreceptor ROS<SUP> </SUP>were incubated in PBS containing 1% dodecyl-&#223;-maltoside<SUP> </SUP>at 4&#176;C for 1 h. Sucrose in the ROS solution was removed<SUP> </SUP>by repeated concentration and dilution with the same buffer<SUP> </SUP>using an ultracentrifuge filter tube (5-kDa molecular mass cut-off;<SUP> </SUP>Millipore, Bedford, MA). Lipids were extracted from ROS with<SUP> </SUP>an equal volume of chloroform:methanol (2:1 v/v), and proteins<SUP> </SUP>in the aqueous phase were collected, dried, and redissolved<SUP> </SUP>in IEF solvent B. Proteins in retinal and ROS extracts were<SUP> </SUP>quantified by a modified Bradford procedure (<A HREF="#R20">20</A>). For one-dimensional<SUP> </SUP>gel electrophoresis, retinal extracts and ROS preparations in<SUP> </SUP>solvent B were diluted 1:1 with Laemmli SDS-PAGE sample buffer,<SUP> </SUP>and electrophoresis was performed according to Laemmli (<A HREF="#R21">21</A>)<SUP> </SUP>using the Bio-Rad Mini-Protein II system.<SUP> </SUP><P>

Two-dimensional gel electrophoresis was performed with the IPGphor/IsoDalt<SUP> </SUP>systems (Amersham Biosciences) as described by West <I>et al.</I> (<A HREF="#R22">22</A>).<SUP> </SUP>First dimension IEF was performed with the IPGphor system in<SUP> </SUP>IEF solvent B using 18 cm of non-linear pH 3&#150;10 immobilized<SUP> </SUP>pH gradient strips and a programmed voltage gradient (<A HREF="#R22">22</A>). After<SUP> </SUP>the first dimension IEF, the strips were incubated in 10 ml<SUP> </SUP>of reducing solution (50 m<FONT SIZE=-2>M</FONT> Tris-HCl, pH 8.8, 6 <FONT SIZE=-2>M</FONT> urea, 100<SUP> </SUP>m<FONT SIZE=-2>M</FONT> dithiothreitol, 30% glycerol, 2% SDS) for 15 min at room<SUP> </SUP>temperature and then in 10 ml of alkylation solution (50 m<FONT SIZE=-2>M</FONT><SUP> </SUP>Tris-HCl, pH 8.8, 6 <FONT SIZE=-2>M</FONT> urea, 250 m<FONT SIZE=-2>M</FONT> iodoacetoamide, 30% glycerol,<SUP> </SUP>2% SDS) for 15 min at room temperature. For the second dimension,<SUP> </SUP>the immobilized pH gradient strips were embedded in 0.7% (w/v)<SUP> </SUP>agarose on the top of 12% acrylamide slab gels (23.5 <FONT FACE="arial,helvetica">x</FONT> 18.0<SUP> </SUP><FONT FACE="arial,helvetica">x</FONT> 0.15 cm) containing a 4% stacking gel, and SDS-PAGE was performed<SUP> </SUP>overnight at 20&#150;30 mA/gel with the IsoDalt system (<A HREF="#R22">22</A>).<SUP> </SUP>Gels were stained with colloidal Coomassie Blue (Pierce Code<SUP> </SUP>Blue) according to the vendor. Detection limits of the stain<SUP> </SUP>were determined to be <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">15 ng of protein on 1.5-mm-thick gels<SUP> </SUP>based on quantitative analyses with BSA (quantified by amino<SUP> </SUP>acid analysis) and a commercial preparation of molecular weight<SUP> </SUP>markers (catalogue number 161&#150;0304; Bio-Rad).<SUP> </SUP><P>

<STRONG><EM>Western Analysis&#151;</EM></STRONG><BR>

For Western blot analysis, proteins in 2D gels were partially<SUP> </SUP>transferred to PVDF membranes (Millipore, Bedford, MA) at 320<SUP> </SUP>mA/gel for 25 min using a Semi Dry Transfer Cell (Bio-Rad).<SUP> </SUP>Proteins remaining in the gels were visualized by colloidal<SUP> </SUP>Coomassie Blue and excised for identification. Two PVDF membranes<SUP> </SUP>were used for each set of Western analysis. One membrane was<SUP> </SUP>chemically reduced before Western analysis, and another membrane<SUP> </SUP>was used for Western analysis without reduction. Reduction of<SUP> </SUP>nitrotyrosine to aminotyrosine was achieved by treating one<SUP> </SUP>membrane with 10 m<FONT SIZE=-2>M</FONT> sodium dithionite in 50 m<FONT SIZE=-2>M</FONT> pyridine-acetate<SUP> </SUP>buffer, pH 5.0, for 1 h at room temperature. After the reaction,<SUP> </SUP>the membrane was rinsed with distilled water and then equilibrated<SUP> </SUP>with wash solution 1 (20 m<FONT SIZE=-2>M</FONT> Tris, 150 m<FONT SIZE=-2>M</FONT> NaCl, pH 7.5, 0.2%<SUP> </SUP>Tween 20). The reduced and non-reduced PVDF membranes were blocked<SUP> </SUP>for 1 h at room temperature in blocking solution (20 m<FONT SIZE=-2>M</FONT> Tris,<SUP> </SUP>150 m<FONT SIZE=-2>M</FONT> NaCl, pH 7.5, 0.2% Tween 20, 1% bovine serum albumin).<SUP> </SUP>The membranes were then probed as before (<A HREF="#R4">4</A>) with a monoclonal<SUP> </SUP>antibody against 3-nitrotyrosine (1:3,000 dilution; Upstate<SUP> </SUP>Biotechnology, Lake Placid, NY) for 2 h at 4&#176;C in blocking<SUP> </SUP>solution. The membranes were then washed five times in wash<SUP> </SUP>solution 1 and probed with horseradish peroxidase-conjugated<SUP> </SUP>secondary antibody (1:10,000 dilution; Amersham Biosciences)<SUP> </SUP>for 1 h at room temperature in blocking solution. After washing<SUP> </SUP>the membranes five times with wash solution 2 (20 m<FONT SIZE=-2>M</FONT> Tris, 150<SUP> </SUP>m<FONT SIZE=-2>M</FONT> NaCl, pH 7.5), immunoreactive proteins were visualized on<SUP> </SUP>x-ray film using a chemiluminescent protein detection system<SUP> </SUP>(Amersham Biosciences). Nitrated BSA was used as a positive<SUP> </SUP>standard protein. X-ray film and gels were scanned with a GS-710<SUP> </SUP>imaging densitometer (Bio-Rad), and the intensity of chemiluminescence<SUP> </SUP>and of Coomassie Blue staining was measured using PDQest 2D<SUP> </SUP>Gel Analysis Software, Version 6 (Bio-Rad).<SUP> </SUP><P>

<STRONG><EM>Preparation of Nitrated BSA&#151;</EM></STRONG><BR>

BSA was nitrated by incubating the protein (10 &#181;<FONT SIZE=-2>M</FONT>) with<SUP> </SUP>50 m<FONT SIZE=-2>M</FONT> tetranitromethane in 100 &#181;l of 50 m<FONT SIZE=-2>M</FONT> Tris-HCl, pH<SUP> </SUP>8.0, at room temperature. After 5 min, the reaction was stopped<SUP> </SUP>by applying the preparation to a gel filtration column (Sephadex<SUP> </SUP>G-25, 1 <FONT FACE="arial,helvetica">x</FONT> 5 cm; Pharmacia Biotech) equilibrated in 0.1% formic<SUP> </SUP>acid. The nitrated and desalted BSA was quantified by phenylthiocarbamyl<SUP> </SUP>amino acid analysis using an Applied Biosystems model 420H/130/920<SUP> </SUP>automated analysis system (<A HREF="#R23">23</A>). Nitrated BSA (30 &#181;g) was<SUP> </SUP>added to 200 m<FONT SIZE=-2>M</FONT> ammonium bicarbonate, pH 8, containing 8 <FONT SIZE=-2>M</FONT> urea,<SUP> </SUP>diluted 1:4, and digested with 1 &#181;g of trypsin (Promega,<SUP> </SUP>Madison, WI) at 37&#176;C overnight under argon.<SUP> </SUP><P>

<STRONG><EM>Protein Identification by MALDI-TOF Mass Spectrometry&#151;</EM></STRONG><BR>

Identification of anti-nitrotyrosine reactive proteins by peptide<SUP> </SUP>mass mapping was as described previously (<A HREF="#R4">4</A>, <A HREF="#R22">22</A>). To facilitate<SUP> </SUP>localization of immunoreactive spots in stained gels, Western<SUP> </SUP>profiles were transferred to a transparency with an office copy<SUP> </SUP>machine and enlarged to the size of the gel after staining.<SUP> </SUP>By overlaying the Western transparency on the stained gel, immunoreactivity<SUP> </SUP>on the membrane was correlated with specific gel spots. To determine<SUP> </SUP>how much to enlarge the Western blot transparency, gel dimensions<SUP> </SUP>were measured on the PVDF membrane after the blotting and compared<SUP> </SUP>with gel dimensions after staining. Briefly, the 2D gel spots<SUP> </SUP>were excised, Coomassie Blue was washed away, and proteins were<SUP> </SUP>digested in-gel with trypsin (Promega, Madison, WI) in 15 m<FONT SIZE=-2>M</FONT><SUP> </SUP><I>N</I>-ethylmorpholine acetate, pH 8.6. Peptides were extracted from<SUP> </SUP>in-gel digests with 60% acetonitrile containing 0.1% trifluoroacetic<SUP> </SUP>acid, dried in a Speed Vac, redissolved in 0.1% trifluoroacetic<SUP> </SUP>acid, and adsorbed onto C18 ZipTips (Millipore, Bedford, MA).<SUP> </SUP>Following ZipTip elution with 7 &#181;l of 75% acetonitrile,<SUP> </SUP>0.02% trifluoroacetic acid, peptides were subjected (1 &#181;l)<SUP> </SUP>to mass spectrometric analysis using a Voyager DE Pro MALDI-TOF<SUP> </SUP>mass spectrometer (PE Biosystems, Framingham, MA). Measured<SUP> </SUP>peptide masses were used to query the Swiss Protein, TrEMBL,<SUP> </SUP>and NCBI sequence databases for matches using MS-Fit and Profound<SUP> </SUP>search programs. All searches were performed with a mass tolerance<SUP> </SUP>of 50 ppm. Positive identification required a minimum of five<SUP> </SUP>peptide matches and the highest probability ranking in both<SUP> </SUP>of the search programs employed.<SUP> </SUP><P>

<STRONG><EM>Protein Identification and Nitrotyrosine Analysis by LC MS/MS&#151;</EM></STRONG><BR>

LC MS/MS was also used to analyze immunoreactive gel spots and<SUP> </SUP>nitrated BSA. Tryptic digests of gel spots (<IMG SRC="/math/le.gif" ALT="<=" BORDER="0">6 &#181;l) were<SUP> </SUP>diluted with 0.1% formic acid (10 &#181;l), and 10 &#181;l<SUP> </SUP>were injected by autosampler onto a 0.3 <FONT FACE="arial,helvetica">x</FONT> 1-mm trapping column<SUP> </SUP>(PepMap C18; LC Packings) using a CapLC system (Micromass),<SUP> </SUP>a switching valve (Micromass), and a flow rate of 5 &#181;l/min.<SUP> </SUP>Solvent pumps were set at 8 &#181;l/min, and the flow rate<SUP> </SUP>was controlled with a splitter in front of the switching valve.<SUP> </SUP>Peptides were eluted at 250 nl/min and chromatographed on a<SUP> </SUP>50-&#181;m <FONT FACE="arial,helvetica">x</FONT> 5-cm Biobasic C18 column (New Objective, Cambridge,<SUP> </SUP>MA) with a gradient of 5&#150;40% acetonitrile over 20 min<SUP> </SUP>followed by 80% acetonitrile for 5 min. The eluent was direct<SUP> </SUP>into a quadrupole time-of-flight mass spectrometer (QTOF2; Micromass,<SUP> </SUP>Beverly, MA) and ionized immediately using an electrosprayer<SUP> </SUP>designed in-house. The mass spectrometer was operated in standard<SUP> </SUP>MS/MS switching mode with the three most intense ions in each<SUP> </SUP>survey scan subjected to MS/MS analysis. In addition, the "include<SUP> </SUP>function" of the instrument operating software was used to program<SUP> </SUP>MS/MS analysis of precursor ions of all possible nitrotyrosine-containing<SUP> </SUP>tryptic peptides based on the structure of the proteins preidentified<SUP> </SUP>by MALDI-TOF MS (calculated as doubly and triply charged ions).<SUP> </SUP>Protein identifications and MS/MS data analyses utilized Micromass<SUP> </SUP>software ProteinLynx<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> Global Server, MassLynx<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> Version 3.5,<SUP> </SUP>and the Swiss-Protein and NCBI protein sequence databases (January<SUP> </SUP>2002). MS/MS spectra of possible nitrated peptides were examined<SUP> </SUP>manually to determine sites of modification.<SUP> </SUP><P>

The relative amount of nitration at each nitration site in BSA<SUP> </SUP>was estimated based on the ion intensity of the nitrotyrosine-containing<SUP> </SUP>peptides, essentially as described for estimating relative amounts<SUP> </SUP>of glycosylation (<A HREF="#R24">24</A>). First the observed ion intensities for<SUP> </SUP>each charge state of a nitrated peptide were summed and then<SUP> </SUP>the total intensity for each nitrated plus unmodified peptide<SUP> </SUP>was calculated. The relative amount of nitration at the site<SUP> </SUP>was estimated as percent of the total intensity.<SUP> </SUP><P>

<STRONG><EM>Immunocytochemistry&#151;</EM></STRONG><BR>

Eyes enucleated immediately after the light exposure were used<SUP> </SUP>for immunocytochemical analyses (<A HREF="#R25">25</A>). After separating the anterior<SUP> </SUP>segment, posterior eye cups were fixed in 4% paraformaldehyde<SUP> </SUP>in PBS for 4 h at 4&#176;C. The eyes were then cryoprotected<SUP> </SUP>in 30% sucrose overnight and embedded in optimal cutting temperature<SUP> </SUP>compound. Cryosections (16-&#181;m) were prepared on gelatin-coated<SUP> </SUP>slides and stored at -80&#176;C until use. Rats without light<SUP> </SUP>exposure were used as control animals. After air drying, sections<SUP> </SUP>were washed in PBS for 10 min and then incubated in PBS containing<SUP> </SUP>5% BSA (Sigma) and 0.3% Triton X-100 for 1.5 h. The sections<SUP> </SUP>were then probed with mouse monoclonal anti-nitrotyrosine antibody<SUP> </SUP>(1:100 dilution; Upstate Biotechnology, Lake Placid, NY) in<SUP> </SUP>PBS containing 0.2% BSA and 0.2% Tween 20 overnight at 4&#176;C.<SUP> </SUP>Fluorescein-conjugated anti-mouse IgG was used as secondary<SUP> </SUP>antibody (1:200 dilution, 1 h incubation at 4&#176;C; Jackson<SUP> </SUP>ImmunoResearch Laboratories, Inc., West Grove, PA). Sections<SUP> </SUP>were mounted with mounting medium (Vector Laboratories Inc.,<SUP> </SUP>Burlingame, CA), and normal mouse IgG was used as a control<SUP> </SUP>for the primary antibody. A total of 16 eyes (8 light-exposed<SUP> </SUP>and 8 control) were analyzed with a Leica TCS SP2 laser scanning<SUP> </SUP>confocal microscope (Leica Microsystems Inc., Heidelberg, Germany).<SUP> </SUP>Images were captured from the posterior area of the retina,<SUP> </SUP>and more than 20 sections were examined per eye. The intensity<SUP> </SUP>of immunohistochemical reactivity was quantified using Quantity<SUP> </SUP>One software (Bio-Rad) after converting the color images from<SUP> </SUP>the confocal microscope to grayscale images in Adobe PhotoShop.<SUP> </SUP><P>

<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
RESULTS
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>RESULTS</FONT><BR>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">DISCUSSION<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG><EM>Improved 2D Gel Western Detection of Nitrotyrosine-containing Proteins&#151;</EM></STRONG><BR>

To distinguish between specific and nonspecific nitrotyrosine<SUP> </SUP>immunoreactivity, we modified previously described methodology<SUP> </SUP>(<A HREF="#R4">4</A>) and performed Western analyses before and after converting<SUP> </SUP>protein nitrotyrosine to aminotyrosine, as summarized in <A HREF="#F1">Fig. 1</A>.<SUP> </SUP>Chemical reduction was achieved by treating PVDF-immobilized<SUP> </SUP>proteins with 10 m<FONT SIZE=-2>M</FONT> sodium dithionite in 50 m<FONT SIZE=-2>M</FONT> pyridine acetate,<SUP> </SUP>pH 5.0, at room temperature for 1 h. Before reduction, nitrated<SUP> </SUP>BSA exhibited strong nitrotyrosine immunoreactivity in Western<SUP> </SUP>analysis, and after reduction, the protein exhibited no immunoreactivity<SUP> </SUP>(<A HREF="#F2">Fig. 2</A>, <I>lanes 2</I> and <I>4</I>). Western analyses of rat retinal proteins<SUP> </SUP>with and without dithionite reduction are also shown in <A HREF="#F2">Fig. 2</A><SUP> </SUP>(<I>lanes 1</I> and <I>3</I>). Two bands, <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">55 and 60 kDa, retain immunoreactivity<SUP> </SUP>after dithionite treatment, suggesting that these are false<SUP> </SUP>positives. Thus, Western analysis before and after dithionite<SUP> </SUP>reduction of membrane-immobilized proteins facilitates the identification<SUP> </SUP>of specific and nonspecific anti-nitrotyrosine antibody recognition.<SUP> </SUP><P>

<A NAME="F1"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F1"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=139 SRC="/content/vol1/issue4/images/small/jw0320034001.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (21K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F1"
    onClick="startTarget('F1', 590, 505); this.href='/cgi/content-nw/full/1/4/293/F1'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 1. <B>Method for identification of nitrotyrosine-containing proteins.</B> Protein samples are separated in duplicate by 2D-PAGE and partially electrotransferred to PVDF membrane. One of the two membranes is treated with dithionite, and both are subjected to Western analysis with anti-nitrotyrosine antibody. Gels are stained with colloidal Coomassie Blue or Silver, and spots of interest are localized from the Western blots and excised for protein identification. Nitrotyrosine loses anti-nitrotyrosine antibody reactivity following reduction to aminotyrosine; therefore immunoreactive spots remaining after dithionite are false positives. See "Experimental Procedures" for details.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="F2"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F2"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=198 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0320034002.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (104K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F2"
    onClick="startTarget('F2', 586, 640); this.href='/cgi/content-nw/full/1/4/293/F2'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 2. <B>Western analysis before and after reduction of nitrotyrosine to aminotyrosine.</B> A retinal extract from a light-exposed 2-month-old rat (<I>lanes 1</I> and <I>3</I>, 20 &#181;g/lane) and nitrated BSA standard (<I>lanes 2</I> and <I>4</I>, 20 ng/lane) were electrophoresed on 10% SDS-polyacrylamide gels, blotted to PVDF membrane, and probed with a monoclonal anti-nitrotyrosine antibody. Western analysis results are shown without (<I>lanes 1</I> and <I>2</I>) and after (<I>lanes 3</I> and <I>4</I>) membrane treatment with dithionite.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG><EM>Identification and Quantification of Nitration Sites in Chemically Modified Albumin&#151;</EM></STRONG><BR>

Albumin was modified chemically with tetranitromethane, and<SUP> </SUP>sites of nitration were identified and quantified by LC MS/MS<SUP> </SUP>analysis of tryptic peptides to evaluate the detection capabilities<SUP> </SUP>of our experimental approach. Analyses of the nitrated BSA tryptic<SUP> </SUP>digest yielded identification of four sites of tyrosine nitration,<SUP> </SUP>namely Tyr<SUP>161</SUP>, Tyr<SUP>173</SUP>, Tyr<SUP>357</SUP>, and Tyr<SUP>424</SUP> (<A HREF="#F3">Fig. 3</A>). Unmodified<SUP> </SUP>peptides containing each of these residues were also detected.<SUP> </SUP>The relative amount of nitration at each site was estimated<SUP> </SUP>from four independent LC MS/MS analyses of 1&#150;2 pmol of<SUP> </SUP>BSA tryptic digest to be <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">84% at Tyr<SUP>161</SUP>, <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">44% at Tyr<SUP>173</SUP>, <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">5% at<SUP> </SUP>Tyr<SUP>357</SUP>, and <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">75% at Tyr<SUP>424</SUP>. Detection sensitivity of nitrotyrosine-containing<SUP> </SUP>peptides was evaluated by LC MS/MS analysis of 1&#150;1000<SUP> </SUP>fmol of the nitrated BSA tryptic digest. The limits of detection<SUP> </SUP>for nitrotyrosine-containing peptides from this preparation<SUP> </SUP>of BSA were determined to be 4 to 33 fmol (see <A HREF="#T1">Table I</A>, and<SUP> </SUP>see <A HREF="#F3">Fig. 3</A>).<SUP> </SUP><P>

<A NAME="F3"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F3"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=142 SRC="/content/vol1/issue4/images/small/jw0320034003.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (42K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F3"
    onClick="startTarget('F3', 590, 512); this.href='/cgi/content-nw/full/1/4/293/F3'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 3. <B>Sites of tyrosine nitration in teranitromethane-modified BSA.</B> MS/MS spectra are shown identifying Tyr<SUP>161</SUP>, Tyr<SUP>173</SUP>, Tyr<SUP>357</SUP>, and Tyr<SUP>424</SUP> as nitrated residues in tetranitromethane-modified BSA. <I>A</I> and <I>E</I>, BSA residues 161&#150;167; <I>B</I> and <I>F</I>, BSA residues 169&#150;183; <I>C</I> and <I>G</I>, BSA residues 347&#150;359; and <I>D</I> and <I>H</I>, BSA residues 421&#150;433. The spectra in <I>A</I>&#150;<I>D</I> were from LC MS/MS analysis of 1 pmol of nitrated BSA digest. The spectra in <I>E</I>&#150;<I>H</I> represent the lowest detectable amounts, namely (<I>E</I>) nY<SUP>161</SUP>, 5 fmol analyzed; (<I>F</I>) nY<SUP>173</SUP>, 75 fmol analyzed; (<I>G</I>) nY<SUP>357</SUP>, 250 fmol analyzed; (<I>H</I>) nY<SUP>424</SUP>, 5 fmol analyzed. Quantitative results are summarized in <A HREF="#T1">Table I</A>. Calculated and observed precursor ions include doubly charged nitrated peptides <I>m</I>/<I>z</I> 486.7 (for nY<SUP>161</SUP> peptide), <I>m</I>/<I>z</I> 806.9 (for nY<SUP>357</SUP> peptide), and <I>m</I>/<I>z</I> 762.9 (for nY<SUP>424</SUP> peptide) and triply charged <I>m</I>/<I>z</I> 645.3 (for nY<SUP>173</SUP> peptide).<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="T1"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/T1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/T1"
    onClick="startTarget('T1', 500, 400); this.href='/cgi/content-nw/full/1/4/293/T1'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
T<FONT SIZE=-2>ABLE</FONT> I Detection of tyrosine nitration sites in tetranitromethane-modified BSA<P>

BSA was modified with tetranitromethane, quantified by amino acid analysis, and digested with trypsin, and four sites of tyrosine nitration were identified by LC MS/MS (see <A HREF="#F3">Fig. 3</A>). The peptide containing nY<SUP>161</SUP> = nYLYEIAR (residues 161&#150;167; nY<SUP>173</SUP> peptide = HPYFnYAPELLYYANK (residues 169&#150;183); nY<SUP>357</SUP> peptide = DAFLGSFLYEnYSR (residues 347&#150;359); nY<SUP>424</SUP> peptide = LGEnYGFQNALIVR (residues 421&#150;433). The amount of each nitrotyrosine peptide was estimated from the degree of nitration as described in the text.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG><EM>Identification of Anti-nitrotyrosine Reactive Proteins in Rat Retina Before and After Light Exposure&#151;</EM></STRONG><BR>

Retinas were isolated from a rat exposed to intense green light<SUP> </SUP>and another rat maintained in the dark, retinal proteins were<SUP> </SUP>fractionated by 2D gel electrophoresis, and nitrotyrosine-containing<SUP> </SUP>proteins were determined by Western analysis. A total of nine<SUP> </SUP>nitrotyrosine-immunopositive gel spots were detected in retinal<SUP> </SUP>extracts from control animals without light exposure (<A HREF="#F4">Fig. 4<I>A</I></A>),<SUP> </SUP>and 12 were detected from light-exposed animals (<A HREF="#F4">Fig. 4<I>B</I></A>). The<SUP> </SUP>immunoreactivity of spots 1 and 8 was significantly more intense<SUP> </SUP>in light-exposed than in control retina, whereas the intensity<SUP> </SUP>of spots 6, 7, and 9 appeared equal in both control and light-exposed<SUP> </SUP>retina. Following treatment with dithionite, spots 1, 9, 14,<SUP> </SUP>and 16 retained some immunoreactivity, suggesting that these<SUP> </SUP>are false positives (<A HREF="#F4">Fig. 4, <I>C</I> and <I>D</I></A>). Thus specific nitrotyrosine<SUP> </SUP>immunoreactivity appears to be associated with spots 2&#150;5<SUP> </SUP>in the dark, spots 10&#150;13 and 15 following light exposure,<SUP> </SUP>and spots 6&#150;8 in both control and light-exposed animals.<SUP> </SUP>The amount of immunoreactive protein remaining in the gel following<SUP> </SUP>partial electrotransfer was estimated to be <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">15&#150;274 ng<SUP> </SUP>per gel spot based on colloidal Coomassie Blue staining intensity<SUP> </SUP>(<A HREF="#T2">Table II</A>).<SUP> </SUP><P>

<A NAME="F4"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F4"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=146 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0320034004.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (91K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F4"
    onClick="startTarget('F4', 472, 640); this.href='/cgi/content-nw/full/1/4/293/F4'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 4. <B>Rat retinal proteins before and after light exposure.</B> 2D-PAGE analyses of retinal homogenates (300 &#181;g of protein/gel) are shown from rats exposed to intense green light (<I>B</I>, <I>D</I>, and <I>F</I>) or control rats maintained in the dark (<I>A</I>, <I>C</I>, and <I>E</I>). Western blot results using anti-nitrotyrosine antibody are shown in <I>A</I>&#150;<I>D</I>, and Coomassie Blue-stained gels are shown in <I>E</I> and <I>F</I>. Western results in <I>A</I> and <I>B</I> are without dithionite treatment, and those in <I>C</I> and <I>D</I> are after dithionite reduction. Proteins identified in the numbered gel spots are listed in <A HREF="#T2">Table II</A>.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="T2"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/T2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/T2"
    onClick="startTarget('T2', 500, 400); this.href='/cgi/content-nw/full/1/4/293/T2'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
T<FONT SIZE=-2>ABLE</FONT> II Retinal proteins in nitrotyrosine immunoreactive gel spots<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


Immunopositive protein spots were excised from the colloidal<SUP> </SUP>Coomassie Blue-stained gels (<A HREF="#F4">Fig. 4, <I>E</I> and <I>F</I></A>) and digested with<SUP> </SUP>trypsin, and peptides were analyzed first by peptide mass mapping<SUP> </SUP>using MALDI-TOF mass spectrometry and then by sequence analysis<SUP> </SUP>using LC MS/MS (<A HREF="#T2">Table II</A>). MALDI-TOF MS provided single protein<SUP> </SUP>identifications for 15 of the 16 gel spots analyzed. LC MS/MS<SUP> </SUP>analysis confirmed the presence of all proteins identified by<SUP> </SUP>MALDI and identified additional proteins in 10 of the 2D gel<SUP> </SUP>spots. All nitrotyrosine-containing peptides were below detection<SUP> </SUP>limits. Proteins only identified from retina maintained in the<SUP> </SUP>dark were aldolase C, aldolase A, aspartate aminotransferase,<SUP> </SUP>glyceraldehyde-3-phosphate dehydrogenase, and annexin II. Proteins<SUP> </SUP>detected only from light-exposed retina were heat shock protein<SUP> </SUP>70, dihydropyrimidinase-related protein 2, serum albumin, protein<SUP> </SUP>disulfide isomerase, glutamate dehydrogenase, and &#223;A3/A1<SUP> </SUP>crystallin. Additional proteins detected in gel spots that were<SUP> </SUP>immunopositive from both light-exposed and dark control retinas<SUP> </SUP>included heterogeneous nuclear ribonucleoprotein, voltage-dependent<SUP> </SUP>anion channel 1, malate dehydrogenase, &#223;B3 crystallin,<SUP> </SUP>and three hypothetical/unknown proteins. Several other proteins<SUP> </SUP>were identified in spots that retain some immunoreactivity following<SUP> </SUP>reduction with dithionite. These proteins are considered potential<SUP> </SUP>false positives and include transducin &#223;1, ATP synthase<SUP> </SUP>D, two hypothetical proteins, and &#223;B2-, &#223;A4-<SUP> </SUP>and <IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0">-crystallin. Essentially the same results as in <A HREF="#F4">Fig. 4</A> and<SUP> </SUP><A HREF="#T2">Table II</A> were reproduced in identical analyses with a dark control<SUP> </SUP>rat and another light-exposed animal.<SUP> </SUP><P>

<STRONG><EM>Immunocytochemical Localization of Nitrotyrosine Before and After Light Exposure&#151;</EM></STRONG><BR>

To localize nitrotyrosine-containing proteins within the layers<SUP> </SUP>and cell types of the retina, we performed immunocytochemical<SUP> </SUP>analyses of rat retina from animals with and without light exposure.<SUP> </SUP>The immunocytochemical results revealed more nitrotyrosine immunoreactivity<SUP> </SUP>in the photoreceptor outer segments of animals maintained under<SUP> </SUP>dark conditions (<A HREF="#F5">Fig. 5<I>A</I></A>). Following light exposure, nitrotyrosine<SUP> </SUP>immunoreactivity almost disappeared in the photoreceptor outer<SUP> </SUP>segments but increased in the RPE and photoreceptor inner segments<SUP> </SUP>(<A HREF="#F5">Fig. 5<I>B</I></A>). Based on image analysis (<A HREF="#F5">Fig. 5<I>D</I></A>), the relative intensity<SUP> </SUP>of immunoreactivity increased <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">20% in the RPE and photoreceptor<SUP> </SUP>inner segments and decreased <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">90% in the photoreceptor outer<SUP> </SUP>segments after light exposure. Nitrotyrosine immunoreactivity<SUP> </SUP>in these regions of the retina was significantly above the background<SUP> </SUP>level immunofluorescence observed with normal mouse IgG (<A HREF="#F5">Fig.<SUP> </SUP>5<I>C</I></A>). The outer plexiform layer of the retina also exhibited<SUP> </SUP>substantial levels of nitrotyrosine immunoreactivity with or<SUP> </SUP>without light exposure. Comparable results to those in <A HREF="#F5">Fig. 5</A><SUP> </SUP>were obtained in immunocytochemical analyses with four light-exposed<SUP> </SUP>and four control rats.<SUP> </SUP><P>

<A NAME="F5"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F5"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=140 SRC="/content/vol1/issue4/images/small/jw0320034005.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (66K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F5">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F5"
    onClick="startTarget('F5', 590, 508); this.href='/cgi/content-nw/full/1/4/293/F5'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F5">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 5. <B>Nitrotyrosine immunocytochemistry before and after light exposure.</B> Representative immunohistochemical analyses of retinal sections with anti-nitrotyrosine antibody are shown from rats maintained in the dark (<I>A</I>), exposed to intense green light (<I>B</I>), or probed with normal mouse IgG from a dark-maintained control animal (<I>C</I>). A comparison of the relative intensity of the immunoreactivity in <I>panels A</I>&#150;<I>C</I> is shown in <I>D</I>. Comparable results were obtained from retinal sections from a total of eight light-exposed eyes and eight dark control eyes. The cell layers of the retina are labeled in <I>A</I> and <I>D</I> and include the following: <I>GCL</I>, ganglion cell layer; <I>IPL</I>, inner plexiform layer; <I>INL</I>, inner nuclear layer; <I>OPL</I>, outer plexiform layer; <I>IS</I>, photoreceptor inner segments; <I>OS</I>, photoreceptor outer segments; and <I>RPE</I>, retinal pigment epithelium cells.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG><EM>Nitrotyrosine Immunoreactivity in Photoreceptor Outer Segments&#151;</EM></STRONG><BR>

Photoreceptor ROS were isolated from animals exposed to intense<SUP> </SUP>green light or maintained in the dark, and ROS proteins were<SUP> </SUP>compared by Western analysis using image analysis to quantify<SUP> </SUP>the intensity of nitrotyrosine immunoreactivity. With or without<SUP> </SUP>reduction with dithionite, the overall intensity of immunoreactivity<SUP> </SUP>in the ROS preparations from animals maintained under dark conditions<SUP> </SUP>was three to four times greater than that from light-exposed<SUP> </SUP>animals (<A HREF="#F6">Fig. 6<I>A</I></A>), supporting the results obtained by immunocytochemistry.<SUP> </SUP>Reduction with dithionite (<A HREF="#F6">Fig. 6<I>B</I></A>) resulted in a loss of nitrotyrosine<SUP> </SUP>immunoreactivity in ROS preparations from both dark-maintained<SUP> </SUP>(55% loss) and light-exposed animals (67% loss). The substantial<SUP> </SUP>loss of immunoreactivity, including that of nitrated standard<SUP> </SUP>protein BSA (<A HREF="#F6">Fig. 6<I>B</I></A>, <I>lane 5</I>), supports the presence of nitrotyrosine-containing<SUP> </SUP>proteins in ROS.<SUP> </SUP><P>

<A NAME="F6"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/293/F6"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=129 SRC="/content/vol1/issue4/images/small/jw0320034006.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (79K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/293/F6">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/293/F6"
    onClick="startTarget('F6', 590, 484); this.href='/cgi/content-nw/full/1/4/293/F6'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F6">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 6. <B>Photoreceptor outer segment proteins before and after light exposure.</B> Western blot results with anti-nitrotyrosine antibody are shown with (<I>B</I>) and without (<I>A</I>) dithionite treatment for photoreceptor outer segment proteins (10 &#181;g/<I>lane</I>) from three different rats maintained in the dark (<I>lanes 1</I> and <I>2</I>) and from three other rats after exposure to intense green light (<I>lanes 3</I> and <I>4</I>). Nitrated BSA standard was applied to <I>lane 5</I> (20 ng/<I>lane</I>).<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
DISCUSSION
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>DISCUSSION</FONT><BR>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

This study has sought improved methods of analysis for protein<SUP> </SUP>nitrotyrosine and evidence of a role for protein nitration in<SUP> </SUP>the mechanism of retinal light damage. Because immunological<SUP> </SUP>methods remain critical for the detection of nitration targets<SUP> </SUP>yet are subject to possible nonspecific antibody cross reactivity,<SUP> </SUP>we have utilized a D gel Western detection strategy that involves<SUP> </SUP>chemical modification of nitrotyrosine. Converting membrane-immobilized<SUP> </SUP>protein nitrotyrosine to aminotyrosine with dithionite (see<SUP> </SUP><A HREF="#F2">Fig. 2</A> and <A HREF="#F6">Fig. 6</A>) prevents specific recognition by anti-nitrotyrosine<SUP> </SUP>antibody (<A HREF="#R5">5</A>). Anti-nitrotyrosine immunoreactivity remaining<SUP> </SUP>on the membrane after dithionite reduction is considered nonspecific.<SUP> </SUP>Dithionite reduction of nitrotyrosine-containing peptides to<SUP> </SUP>aminotyrosine analogs appears to be quantitative in peptides<SUP> </SUP>(<A HREF="#R26">26</A>), and we suspect that for membrane-immobilized proteins,<SUP> </SUP>any nitrotyrosine accessible to antibody recognition will also<SUP> </SUP>be susceptible to modification by this small chemical reducing<SUP> </SUP>agent. Reduction of nitrotyrosine to aminotyrosine has been<SUP> </SUP>used to quantify nitrotyrosine in enzymatic and HCl protein<SUP> </SUP>hydrolysates using electrochemical, UV analysis and in mass<SUP> </SUP>spectrometric methods (<A HREF="#R3">3</A>, <A HREF="#R26">26</A>, <A HREF="#R27">27</A>).<SUP> </SUP><P>

Although the dithionite reduction strategy improves the reliability<SUP> </SUP>of Western detection methods for nitrotyrosine, identification<SUP> </SUP>of nitrated proteins remains challenging, especially for low<SUP> </SUP>abundancy proteins in complex mixtures. Complications include<SUP> </SUP>antibody-inaccessible nitrotyrosine that remains invisible by<SUP> </SUP>Western analysis and multiple potential components in a gel<SUP> </SUP>band or spot. The difference in MALDI-TOF mass spectra before<SUP> </SUP>and after dithionite treatment has been suggested as a method<SUP> </SUP>for identifying nitrotyrosine-containing peptides (<A HREF="#R26">26</A>). However,<SUP> </SUP>none of our MALDI-TOF MS analyses of 2D gel spots or of 2 pmol<SUP> </SUP>of nitrated BSA tryptic digest exhibited the laser-induced decomposition<SUP> </SUP>products reported as possible nitrotyrosine signature ions (<A HREF="#R26">26</A>),<SUP> </SUP>presumably because of insufficient sample amounts. Collision-induced<SUP> </SUP>dissociation in electrospray tandem mass spectrometry produces<SUP> </SUP>an immonium ion (<I>m</I>/<I>z</I> 181.06) from nitrotyrosine that has been<SUP> </SUP>suggested as useful for precursor ion scanning to identify <I>in<SUP> </SUP>vivo</I> sites of nitration (<A HREF="#R28">28</A>). Our attempts to monitor this immonium<SUP> </SUP>ion with the QTOF2 instrument were not informative. We also<SUP> </SUP>pursued precursor ion scanning of the immonium ion using nitrated<SUP> </SUP>BSA tryptic digest (2 pmol) and a triple quadrupole electrospray<SUP> </SUP>instrument (Sciex API 3000). A couple of nitrated albumin peptides<SUP> </SUP>were detected, but the false positive signals described previously<SUP> </SUP>(<A HREF="#R28">28</A>) were problematic, and the detection sensitivity was insufficient<SUP> </SUP>for productive analysis of the rat retinal samples.<SUP> </SUP><P>

By programming the QTOF2 mass spectrometer to perform MS/MS<SUP> </SUP>on all possible nitrotyrosine peptides in BSA regardless of<SUP> </SUP>ion intensity, Tyr<SUP>161</SUP>, Tyr<SUP>173</SUP>, Tyr<SUP>357</SUP>, and Tyr<SUP>424</SUP> were identified<SUP> </SUP>as sites of nitration (<A HREF="#F3">Fig. 3</A>) with detection limits in the<SUP> </SUP>4 to 33 fmol range (<A HREF="#T1">Table I</A>). Several other studies using albumin<SUP> </SUP>modified with either tetranitromethane or peroxynitirite also<SUP> </SUP>identified nitration at Tyr<SUP>161</SUP> (Tyr<SUP>162</SUP> in human serum albumin)<SUP> </SUP>and/or Tyr<SUP>424</SUP> (<A HREF="#R26">26</A>, <A HREF="#R28">28</A>, <A HREF="#R29">29</A>), the most extensively modified sites<SUP> </SUP>in the present study. Other tyrosines reported to be nitrated<SUP> </SUP>in <I>in vitro</I>-modified BSA include Tyr<SUP>54</SUP>, Tyr<SUP>163</SUP>, Tyr<SUP>475</SUP> (<A HREF="#R28">28</A>),<SUP> </SUP>and Tyr<SUP>364</SUP> (<A HREF="#R26">26</A>) and in human serum albumin, Tyr<SUP>435</SUP> (<A HREF="#R29">29</A>). Clearly<SUP> </SUP>the nitrating agent and reaction conditions can influence the<SUP> </SUP>extent of chemical modification; however the factors determining<SUP> </SUP>the selectivity of tyrosine nitration remain unclear. For example,<SUP> </SUP>we observed only one of the four tyrosines nitrated in BSA peptide<SUP> </SUP>HP<I>Y</I>F<I>nY</I>APELL<I>YY</I>ANK (residues 169&#150;183). Limitations of this<SUP> </SUP>detection strategy are that the identity of the nitrated protein<SUP> </SUP>must be known in advance, and nitrated peptides with additional,<SUP> </SUP>unpredicted post-translational modifications will not be detected.<SUP> </SUP><P>

The nitrotyrosine peptide detection strategy used here appears<SUP> </SUP>appropriate for methods development studies of model proteins<SUP> </SUP>like BSA; however additional sensitivity is required for the<SUP> </SUP>routine identification of nitration sites in <I>in vivo</I> samples.<SUP> </SUP>The average 2D gel spot in the present study of rat retinal<SUP> </SUP>proteins (<A HREF="#F4">Fig. 4</A>) contained about 70&#150;80 ng of protein<SUP> </SUP>and multiple components (<A HREF="#T2">Table II</A>). Allowing <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">30% loss during<SUP> </SUP>post-gel sample preparation (<A HREF="#R30">30</A>) and <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">14% consumption for MALDI-TOF<SUP> </SUP>MS, the average amount analyzed by LC MS/MS per gel spot was<SUP> </SUP><IMG SRC="/math/sim.gif" ALT="~" BORDER="0">40&#150;50 ng. No nitrotyrosine was detected in the retinal<SUP> </SUP>samples by mass spectrometry although the analysis strategy<SUP> </SUP>allowed identification of two sites in BSA with only <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">0.3 ng<SUP> </SUP>of tryptic digest (<A HREF="#T1">Table I</A>). Greater sample amounts, enrichment<SUP> </SUP>methods, and/or higher sensitivity will be needed to identify<SUP> </SUP>nitration sites in the retinal samples.<SUP> </SUP><P>

Many of the retinal proteins exhibiting nitrotyrosine immunoreactivity<SUP> </SUP>in this study were also detected with anti-nitrotyrosine antibody<SUP> </SUP>in liver or cultured cells following inflammatory challenge<SUP> </SUP>(<A HREF="#R4">4</A>). Although sites of nitration have not been identified, the<SUP> </SUP>present results nevertheless indicate different nitration events<SUP> </SUP>have occurred in retinal tissue from light-exposed rats compared<SUP> </SUP>with animals maintained in the dark (<A HREF="#T2">Table II</A>). Of the five<SUP> </SUP>proteins only identified in rats maintained in the dark, four<SUP> </SUP>function in energy production, namely fructose bisphosphate<SUP> </SUP>aldolase A and C, aspartate aminotransferase, and glyceraldehyde-3-phosphate<SUP> </SUP>dehydrogenase. Reinforcing the presence of nitrotyrosine in<SUP> </SUP>aldolase was the identification of this protein by LC MS/MS<SUP> </SUP>in two different dithionite-sensitive, immunoreactive gel spots<SUP> </SUP>and that no other proteins were present (see <A HREF="#F4">Fig. 4</A>, and see<SUP> </SUP><A HREF="#T2">Table II</A>). This provides evidence of tyrosine nitration under<SUP> </SUP><I>in vivo,</I> non-pathological conditions and suggests protein nitration<SUP> </SUP>plays a role in normal retinal physiology. Among the unique<SUP> </SUP>proteins only identified in rats exposed to intense light were<SUP> </SUP>mitochondrial enzyme glutamate dehydrogenase, stress response<SUP> </SUP>proteins HSP 70, protein disulfide isomerase, &#223;A3/A1<SUP> </SUP>crystallin, and serum albumin, which carries photolabile <I>S</I>-nitroso<SUP> </SUP>adducts (<A HREF="#R31">31</A>). Protein disulfide isomerase and heterogeneous<SUP> </SUP>nuclear ribonucleoprotein A2/B1, a nuclear RNA-binding protein<SUP> </SUP>of unknown function, were each identified by LC MS/MS as the<SUP> </SUP>sole component of nitrotyrosine-immunoreactive gel spots following<SUP> </SUP>light exposure (<A HREF="#T2">Table II</A>). The <I>in vivo</I> consequences of these<SUP> </SUP>nitration events are not clear; however <I>in vitro</I> studies have<SUP> </SUP>shown that nitration of tyrosine can inhibit the activity of<SUP> </SUP>three of the identified enzymes, namely for aldolase (<A HREF="#R32">32</A>), aspartate<SUP> </SUP>aminotransferase (<A HREF="#R33">33</A>), and glutamate dehydrogenase (<A HREF="#R34">34</A>). Although<SUP> </SUP>we do not know whether all of the proteins in the immunoreactive<SUP> </SUP>spots contain nitrotyrosine, the results demonstrated that retinal<SUP> </SUP>proteins are nitrated in the dark and that exposure to damaging<SUP> </SUP>light changes the nitration targets.<SUP> </SUP><P>

Our immunocytochemical results also showed that the nitration<SUP> </SUP>targets within the cell layers of the rat retina changes with<SUP> </SUP>light exposure. More tyrosine nitration appears in the photoreceptor<SUP> </SUP>outer segments in the dark (<A HREF="#F5">Fig. 5</A>) where endogenous NO produced<SUP> </SUP>by NO synthase is a likely contributing factor. Endogenous NO<SUP> </SUP>has been linked functionally to guanylyl cyclase activity in<SUP> </SUP>photoreceptor cells (<A HREF="#R35">35</A>), suggesting a possible modulatory role<SUP> </SUP>for NO in visual transduction. The present results raise questions<SUP> </SUP>as to whether nitration in photoreceptor outer segments might<SUP> </SUP>participate in modulating disc membrane renewal in the dark<SUP> </SUP>and the rhythmic light/dark regulation of disc shedding at day<SUP> </SUP>break. Increased tyrosine nitration was observed in the photoreceptor<SUP> </SUP>inner segments and RPE following intense light exposure, apparently<SUP> </SUP>because of increased concentrations of reactive nitrogen oxide<SUP> </SUP>species. This mechanism for modification seems particularly<SUP> </SUP>plausible in the inner segments of the photoreceptors where<SUP> </SUP>a major cellular source of reactive oxygen species are concentrated,<SUP> </SUP>namely the mitochondria (<A HREF="#R4">4</A>). Following light exposure, the decrease<SUP> </SUP>in photoreceptor outer segment nitrotyrosine observed by both<SUP> </SUP>immunocytochemical (<A HREF="#F5">Fig. 5</A>) and Western (<A HREF="#F6">Fig. 6</A>) analyses may<SUP> </SUP>in part reflect oxidative stress-induced selective protein degradation<SUP> </SUP>by the proteasome (<A HREF="#R36">36</A>).<SUP> </SUP><P>

Nitrotyrosine is formed from the reaction of free or protein-bound<SUP> </SUP>tyrosine with reactive nitrogen oxide species. The actual species<SUP> </SUP>responsible for tyrosine nitration <I>in vivo</I> continue to be debated;<SUP> </SUP>however free radical nitrogen dioxide (NO<SUB>2</SUB>) (<A HREF="#R37">37</A>) and peroxynitrite<SUP> </SUP>(ONOO<SUP>-</SUP>) (<A HREF="#R38">38</A>) have both been implicated as major contributors.<SUP> </SUP>Nitrogen oxide species also react with cysteine thiols <I>in vivo</I><SUP> </SUP>(<A HREF="#R39">39</A>), and in plasma a majority of the total NO (<I>e.g.</I> 84%) appears<SUP> </SUP>to circulate as <I>S</I>-nitroso adducts of serum albumin (<A HREF="#R31">31</A>). Glutathione<SUP> </SUP>may also serve as a molecular carrier of NO, and because of<SUP> </SUP>the photolability of nitrosothiol compounds, the targeted release<SUP> </SUP>of NO from <I>S</I>-nitrosoglutathione by laser light has been suggested<SUP> </SUP>to have therapeutic applications (<A HREF="#R40">40</A>, <A HREF="#R41">41</A>). In the context of<SUP> </SUP>retinal light damage, photolabile nitrosothiols should be considered<SUP> </SUP>as another source of both nitrating and cytotoxic reactive nitrogen<SUP> </SUP>oxide species.<SUP> </SUP><P>

We have employed a well established <I>in vivo</I> model system for<SUP> </SUP>light damage that typically results in 50% photoreceptor cell<SUP> </SUP>loss in rats within 2 weeks of the light exposure (<A HREF="#R8">8</A>, <A HREF="#R10">10</A>). In<SUP> </SUP>the present study, animals were sacrificed immediately after<SUP> </SUP>light treatment to probe for initial light-induced changes in<SUP> </SUP>protein nitration. Clearly, the cytotoxic effects of nitric<SUP> </SUP>oxide (<A HREF="#R42">42</A>) may also be manifested in retinal light damage. Notably,<SUP> </SUP>excessive nitric oxide has been implicated in retinal damage<SUP> </SUP>in rat models of ocular ischemia (<A HREF="#R43">43</A>) and chronic glaucoma (<A HREF="#R44">44</A>).<SUP> </SUP>Excess reactive nitrogen oxide species not only modify proteins,<SUP> </SUP>lipids, and DNA, but in the retina may also contribute to the<SUP> </SUP>oxidative modification of retinoids in the pathways of light-induced<SUP> </SUP>retinal damage. The present findings justify further consideration<SUP> </SUP>of nitration and nitric oxide as possible mediators in light-induced<SUP> </SUP>photoreceptor cell death.<SUP> </SUP><P>

<SUP> </SUP><P>



<A NAME="FN"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
FOOTNOTES
</FONT></TH></TR></TABLE>
&nbsp;<BR>
Received, December 10, 2001, and in revised form, March  8, 2002.<P>

<A NAME=""><!-- null --></A>
Published, MCP Papers in Press, March 12, 2002, DOI 10.1074/mcp.M100034-MCP200<SUP> </SUP><P>

<A NAME="FN1"><!-- null --></A>
<SUP><SUP>1</SUP></SUP> The abbreviations used are: MALDI-TOF, matrix assisted laser<SUP> </SUP>desorption ionization time of flight; BSA, bovine serum albumin;<SUP> </SUP>IEF, isoelectric focusing; LC, liquid chromatography; MS/MS,<SUP> </SUP>tandem mass spectrometry; NO, nitric oxide; nY, nitrotyrosine;<SUP> </SUP>PBS, phosphate-buffered saline; PVDF: polyvinylidene difluoride;<SUP> </SUP>RPE, retinal pigment epithelium; ROS, rod outer segments; 2D,<SUP> </SUP>two-dimensional; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic<SUP> </SUP>acid.<SUP> </SUP><A HREF="#RFN1"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>
<A NAME="FN2"><!-- null --></A>
<SUP>*</SUP> This work was supported in part by National Institutes of Health<SUP> </SUP>Grants EY06603 (to J. W. C.), NS41644 (to D. J. S.), and EY01959<SUP> </SUP>(to D. T. O.), by a Research Center grant to The Cole Eye Institute<SUP> </SUP>from The Foundation Fighting Blindness, and by funds from the<SUP> </SUP>Cleveland Clinic Foundation.<SUP> </SUP><A HREF="#RFN2"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>


<A NAME="COR1"><!-- null --></A>
<SUP><IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP> To whom correspondence may be addressed: Cole Eye Inst., Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-0424; Fax: 216-445-3670; E-mail: <span id="em0">miyagim{at}ccf.org</span><script type="text/javascript"><!--
 var u = "miyagim", d = "ccf.org"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script><P><A NAME="COR2"><!-- null --></A>
<SUP>**</SUP> To whom correspondence may be addressed: Cole Eye Inst. and Lerner Research Inst., Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-445-0425; Fax: 216-445-3670; E-mail: <span id="em1">crabbj{at}ccf.org</span><script type="text/javascript"><!--
 var u = "crabbj", d = "ccf.org"; document.getElementById("em1").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script><P>

<A NAME="BIBL"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
REFERENCES
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">DISCUSSION<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>REFERENCES</FONT><BR>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<OL COMPACT>
<A NAME="R1"><!-- null --></A>
<LI VALUE=1> Haddad, I. Y., Pataki, G., Hu, P., Galliani, C., Beckman, J. S., and Matalon, S.
(1994) Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.
<I>J. Clin. Invest.</I>
<B>94, </B>2407
&#150;2413<!-- HIGHWIRE ID="1:4:293:1" --><A HREF="/cgi/external_ref?access_num=7989597&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R2"><!-- null --></A>
<LI VALUE=2> Halliwell, B., Zhao, K., and Whiteman, M.
(1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies.
<I>Free Radic. Res.</I>
<B>31, </B>651
&#150;669<!-- HIGHWIRE ID="1:4:293:2" --><A HREF="/cgi/external_ref?access_num=10630688&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R3"><!-- null --></A>
<LI VALUE=3> Shigenaga, M. K., Lee, H. H., Blount, B. C., Christen, S., Shigeno, E. T., Yip, H., and Ames, B. N.
(1997) Inflammation and NO(X)-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>94, </B>3211
&#150;3216<!-- HIGHWIRE ID="1:4:293:3" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=94/7/3211" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R4"><!-- null --></A>
<LI VALUE=4> Aulak, K. S., Miyagi, M., Yan, L., West, K. A., Massillon, D., Crabb, J. W., and Stuehr, D. J.
(2001) Proteomic method identifies proteins nitrated <I>in vivo</I> during inflammatory challenge.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>98, </B>12056
&#150;12061<!-- HIGHWIRE ID="1:4:293:4" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=98/21/12056" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R5"><!-- null --></A>
<LI VALUE=5> Haqqani, A. S., Kelly, J. F., and Birnboim, H. C.
(2002) Selective nitration of histone tyrosine residues <I>in vivo</I> in mutatect tumors.
<I>J. Biol. Chem.</I>
<B>277, </B>3614
&#150;3621<!-- HIGHWIRE ID="1:4:293:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=277/5/3614" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R6"><!-- null --></A>
<LI VALUE=6> Goureau, O., Jeanny, J. C., Becquet, F., Hartmann, M. P., and Courtois, Y.
(1993) Protection against light-induced retinal degeneration by an inhibitor of NO synthase.
<I>Neuroreport</I>
<B>5, </B>233
&#150;236<!-- HIGHWIRE ID="1:4:293:6" --><A HREF="/cgi/external_ref?access_num=7507723&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R7"><!-- null --></A>
<LI VALUE=7> Noell, W. K., Walker, V. S., Kang, B. S., and Berman, S.
(1966) Retinal damage by light in rats.
<I>Invest. Ophthalmol. Vis. Sci.</I>
<B>5, </B>450
&#150;473<!-- HIGHWIRE ID="1:4:293:7" --><A HREF="/cgi/external_ref?access_num=5929286&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R8"><!-- null --></A>
<LI VALUE=8> Organisciak, D. T., and Winkler, B. S.
(1994) in
<I>Progress in Retinal and Eye Research</I>, (Osborne, N. N., and Chader, G. J., eds) Vol. 13, pp.1
&#150;29, Pergamon Press, Oxford<!-- HIGHWIRE ID="1:4:293:8" --><A HREF="/cgi/external_ref?access_num=10.1016/1350-9462(94)90003-5&link_type=DOI" >[CrossRef]</A><!-- /HIGHWIRE --><P><A NAME="R9"><!-- null --></A>
<LI VALUE=9> Hafezi, F., Steinbach, J. P., Marti, A., Munz, K., Wang, Z. Q., Wagner, E. F., Aguzzi, A., and Reme, C. E.
(1997) The absence of c-<I>fos</I> prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration <I>in vivo</I>.
<I>Nat. Med.</I>
<B>3, </B>346
&#150;349<!-- HIGHWIRE ID="1:4:293:9" --><A HREF="/cgi/external_ref?access_num=9055866&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R10"><!-- null --></A>
<LI VALUE=10> Organisciak, D. T., Darrow, R. A., Barsalou, L., Darrow, R. M., and Lininger, L. A.
(1999) Light-induced damage in the retina differential effects of dimethylthiourea on photoreceptor survival, apoptosis and DNA oxidation.
<I>Photochem. Photobiol.</I>
<B>70, </B>261
&#150;268<!-- HIGHWIRE ID="1:4:293:10" --><A HREF="/cgi/external_ref?access_num=10461466&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R11"><!-- null --></A>
<LI VALUE=11> Williams, T. P., and Howell, W. L.
(1983) Action spectrum of retinal light-damage in albino rats.
<I>Invest. Ophthalmol. Vis. Sci.</I>
<B>24, </B>285
&#150;287<!-- HIGHWIRE ID="1:4:293:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=iovs&resid=24/3/285" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R12"><!-- null --></A>
<LI VALUE=12> Sparrow, J. R., Nakanishi, K., and Parish, C. A.
(2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells.
<I>Invest. Ophthalmol. Vis. Sci.</I>
<B>41, </B>1981
&#150;1989<!-- HIGHWIRE ID="1:4:293:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=iovs&resid=41/7/1981" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R13"><!-- null --></A>
<LI VALUE=13> Sun, H., and Nathans, J.
(2001) ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-<I>trans</I>-retinal-mediated photooxidative damage <I>in vitro</I>. Implications for retinal disease.
<I>J. Biol. Chem.</I>
<B>276, </B>11766
&#150;11774<!-- HIGHWIRE ID="1:4:293:13" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=276/15/11766" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R14"><!-- null --></A>
<LI VALUE=14> Noell, W. K., and Albrecht, R.
(1971) Irreversible effects on visible light on the retina: role of vitamin A.
<I>Science</I>
<B>172, </B>76
&#150;79<!-- HIGHWIRE ID="1:4:293:14" --><A HREF="/cgi/external_ref?access_num=5546288&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R15"><!-- null --></A>
<LI VALUE=15> Saari, J., Nawrot, M., Kennedy, B. N., Garwin, G. G., Hurley, J. B., Huang, J., Possin, D. E., and Crabb, J. W.
(2001) Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation.
<I>Neuron</I>
<B>29, </B>739
&#150;748<!-- HIGHWIRE ID="1:4:293:15" --><A HREF="/cgi/external_ref?access_num=11301032&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R16"><!-- null --></A>
<LI VALUE=16> Wenzel, A., Reme, C. E., Williams, T. P., Hafezi, F., and Grimm, C.
(2001) The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration.
<I>J. Neurosci.</I>
<B>21, </B>53
&#150;58<!-- HIGHWIRE ID="1:4:293:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jneuro&resid=21/1/53" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R17"><!-- null --></A>
<LI VALUE=17> Sieving, P. A., Chaudhry, P., Kondo, M., Provenzano, M., Wu, D., Carlson, T. J., Bush, R. A., and Thompson, D. A.
(2001) Inhibition of the visual cycle <I>in vivo</I> by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>98, </B>1835
&#150;1840<!-- HIGHWIRE ID="1:4:293:17" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=98/4/1835" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R18"><!-- null --></A>
<LI VALUE=18> Delmelle, M., Noell, W. K., and Organisciak, D. T.
(1975) Hereditary retinal dystrophy in the rat: rhodopsin, retinol, vitamin A deficiency.
<I>Exp. Eye Res.</I>
<B>21, </B>369
&#150;380<!-- HIGHWIRE ID="1:4:293:18" --><A HREF="/cgi/external_ref?access_num=1218544&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R19"><!-- null --></A>
<LI VALUE=19> Organisciak, D. T., Wang, H., and Kou, A. L.
(1982) Rod outer segment lipid-opsin ratios in the developing normal and retinal dystrophic rat.
<I>Exp. Eye Res.</I>
<B>34, </B>401
&#150;412<!-- HIGHWIRE ID="1:4:293:19" --><A HREF="/cgi/external_ref?access_num=10.1016/0014-4835(82)90086-0&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=6461559&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R20"><!-- null --></A>
<LI VALUE=20> Ramagli, L. S.
(1999) Quantifying protein in 2-D PAGE solubilization buffers.
<I>Methods Mol. Biol.</I>
<B>112, </B>99
&#150;103<!-- HIGHWIRE ID="1:4:293:20" --><A HREF="/cgi/external_ref?access_num=10027233&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R21"><!-- null --></A>
<LI VALUE=21> Laemmli, U. K.
(1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
<I>Nature</I>
<B>227, </B>680
&#150;685<!-- HIGHWIRE ID="1:4:293:21" --><A HREF="/cgi/external_ref?access_num=5432063&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R22"><!-- null --></A>
<LI VALUE=22> West, K. A., Yan, L., Miyagi, M., Crabb, J. S., Marmorstein, A. D., Marmorstein, L., and Crabb, J. W.
(2001) Proteome survey of proliferating and differentiating rat retinal pigment epithelial J-cells.
<I>Exp. Eye Res.</I>
<B>73, </B>479
&#150;491<!-- HIGHWIRE ID="1:4:293:22" --><A HREF="/cgi/external_ref?access_num=10.1006/exer.2001.1058&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11825020&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R23"><!-- null --></A>
<LI VALUE=23> Crabb, J. W., West, K. A., Dodson, W. S., and Hulmes, J. D.
(1997) in
<I>Current Protocols In Protein Science</I> (Coligan, J. E., Ploegh, H. L., Smith, J. A., and Speicher, D. W., eds) pp.11.9.1
&#150;11.9.42, John Wiley &amp; Sons, Inc., New York<!-- HIGHWIRE ID="1:4:293:23" --><!-- /HIGHWIRE --><P><A NAME="R24"><!-- null --></A>
<LI VALUE=24> Kapron, J. T., Hilliard, G., Lakins, J., Tenniswood, M., West, K. A., Carr, S. A., and Crabb, J. W.
(1997) Identification and characterization of glycosylation sites in human serum clusterin.
<I>Protein Sci.</I>
<B>6, </B>2120
&#150;2133<!-- HIGHWIRE ID="1:4:293:24" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=protsci&resid=6/10/2120" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R25"><!-- null --></A>
<LI VALUE=25> Hollyfield, J. G., Rayborn, M. E., Nishiyama, K., Shadrach, K. G., Miyagi, M., Crabb, J. W., and Rodriguez, I. R.
(2001) Interphotoreceptor matrix in the fovea and peripheral retina of the primate <I>Macaca mulatta</I>: distribution and glycoforms of SPACR and SPACRCAN.
<I>Exp. Eye Res.</I>
<B>72, </B>49
&#150;61<!-- HIGHWIRE ID="1:4:293:25" --><A HREF="/cgi/external_ref?access_num=10.1006/exer.2000.0922&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11133182&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R26"><!-- null --></A>
<LI VALUE=26> Sarver, A., Scheffler, N. K., Shetlar, M. D., and Gibson, B. W.
(2001) Analysis of peptides and proteins containing nitrotyrosine by matrix-assisted laser desorption/ionization mass spectrometry.
<I>J. Am. Soc. Mass Spectrom.</I>
<B>12, </B>439
&#150;448<!-- HIGHWIRE ID="1:4:293:26" --><A HREF="/cgi/external_ref?access_num=10.1016/S1044-0305(01)00213-6&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11322190&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R27"><!-- null --></A>
<LI VALUE=27> Crowley, J. R., Yarasheski, K., Leeuwenburgh, C., Turk, J., and Heinecke, J. W.
(1998) Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine.
<I>Anal. Biochem.</I>
<B>259, </B>127
&#150;135<!-- HIGHWIRE ID="1:4:293:27" --><A HREF="/cgi/external_ref?access_num=10.1006/abio.1998.2635&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9606153&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R28"><!-- null --></A>
<LI VALUE=28> Petersson, A. S., Steen, H., Kalume, D. E., Caidahl, K., and Roepstorff, P.
(2001) Investigation of tyrosine nitration in proteins by mass spectrometry.
<I>J. Mass Spectrom.</I>
<B>36, </B>616
&#150;625<!-- HIGHWIRE ID="1:4:293:28" --><A HREF="/cgi/external_ref?access_num=10.1002/jms.161&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11433534&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R29"><!-- null --></A>
<LI VALUE=29> Jiao, K., Mandapati, S., Skipper, P. L., Tannenbaum, S. R., and Wishnok, J. S.
(2001) Site-selective nitration of tyrosine in human serum albumin by peroxynitirie.
<I>Anal. Biochem.</I>
<B>293, </B>43
&#150;52<!-- HIGHWIRE ID="1:4:293:29" --><A HREF="/cgi/external_ref?access_num=10.1006/abio.2001.5118&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11373077&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R30"><!-- null --></A>
<LI VALUE=30> Speicher, K. D., Kolbas, O., Harper, S., and Speicher, D. W.
(2000) Systematic analysis of peptide recoveries from in-gel digestions for protein identifications in proteome studies.
<I>J. Biomol. Tech.</I>
<B>11, </B>74
&#150;86<!-- HIGHWIRE ID="1:4:293:30" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbt&resid=11/2/74" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R31"><!-- null --></A>
<LI VALUE=31> Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., and Loscalzo, J.
(1992) Nitric oxide circulates in mammalian plasma primarily as an <I>S</I>-nitroso adduct of serum albumin.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>89, </B>7674
&#150;7677<!-- HIGHWIRE ID="1:4:293:31" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=89/16/7674" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R32"><!-- null --></A>
<LI VALUE=32> Gavilanes, F. G., and Gavilanes, J. G.
(1982) Role of tyrosine residues on structure-function of fructose-1,6-bisphosphate aldolase from
<I>Ceratitis capitata. Int. J. Pept. Protein Res.</I>
<B>19, </B>137
&#150;142<!-- HIGHWIRE ID="1:4:293:32" --><!-- /HIGHWIRE --><P><A NAME="R33"><!-- null --></A>
<LI VALUE=33> Di Cola, D., Polidoro, G., Di Ilio, C., Del Boccio, G., Politi, L., and Scandurra, R.
(1976) Role of tyrosine residues in cytoplasmic aspartate aminotransferase from beef kidney.
<I>Mol. Cell. Biochem.</I>
<B>11, </B>97
&#150;101<!-- HIGHWIRE ID="1:4:293:33" --><A HREF="/cgi/external_ref?access_num=1272258&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R34"><!-- null --></A>
<LI VALUE=34> Piszkiewicz, D., Landon, M., and Smith, E. L.
(1971) Bovine glutamate dehydrogenase: loss of allosteric inhibition by guanosine triphosphate and nitration of tyrosine 412.
<I>J. Biol. Chem.</I>
<B>246, </B>1324
&#150;1329<!-- HIGHWIRE ID="1:4:293:34" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=246/5/1324" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R35"><!-- null --></A>
<LI VALUE=35> Koch, K.-W., Lambrecht, H.-G., Haberecht, M., Redburn, D., and Schmidt, H. H. H. W.
(1994) Functional coupling of a Ca<SUP>2+</SUP>/calmodulin-dependent nitric-oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells.
<I>EMBO J.</I>
<B>13, </B>3312
&#150;3320<!-- HIGHWIRE ID="1:4:293:35" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=13/14/3312" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R36"><!-- null --></A>
<LI VALUE=36> Souza, J. M., Choi, I., Chen, Q., Weisse, M., Daikhin, E., Yudkoff, M., Obin, M., Ara, J., Horwitz, J., and Ischiropoulos, H.
(2000) Proteolytic degradation of tyrosine nitrated proteins.
<I>Arch. Biochem. Biophys.</I>
<B>380, </B>360
&#150;366<!-- HIGHWIRE ID="1:4:293:36" --><A HREF="/cgi/external_ref?access_num=10.1006/abbi.2000.1940&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10933892&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R37"><!-- null --></A>
<LI VALUE=37> Squadrito, G. L., and Pryor, W. A.
(1998) Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide.
<I>Free Radic. Biol. Med.</I>
<B>25, </B>392
&#150;403<!-- HIGHWIRE ID="1:4:293:37" --><A HREF="/cgi/external_ref?access_num=10.1016/S0891-5849(98)00095-1&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9741578&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R38"><!-- null --></A>
<LI VALUE=38> Beckman, J. S.
(1996) Oxidative damage and tyrosine nitration from peroxynitrite.
<I>Chem. Res. Toxicol.</I>
<B>9, </B>836
&#150;844<!-- HIGHWIRE ID="1:4:293:38" --><A HREF="/cgi/external_ref?access_num=10.1021/tx9501445&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8828918&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R39"><!-- null --></A>
<LI VALUE=39> Jaffrey, S. R., Erdjument-Bromage, H., Ferris, C. D., Tempst, P., and Snyder, S. H.
(2001) Protein <I>S</I>-nitrosylation: a physiological signal for neuronal nitric oxide.
<I>Nat. Cell Biol.</I>
<B>3, </B>193
&#150;197<!-- HIGHWIRE ID="1:4:293:39" --><A HREF="/cgi/external_ref?access_num=10.1038/35055104&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11175752&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R40"><!-- null --></A>
<LI VALUE=40> Sexton, D. J., Muruganandam, A., McKenney, D. J., and Mutus, B.
(1994) Visible light photochemical release of nitric oxide from <I>S</I>-nitrosoglutathione: potential photochemotherapeutic applications.
<I>Photochem. Photobiol.</I>
<B>59, </B>463
&#150;467<!-- HIGHWIRE ID="1:4:293:40" --><A HREF="/cgi/external_ref?access_num=8022889&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R41"><!-- null --></A>
<LI VALUE=41> Wood, P. D., Mutus, B., and Redmond, R. W.
(1996) The mechanism of photochemical release of nitric oxide from <I>S</I>-nitrosoglutathion.
<I>Photochem. Photobiol.</I>
<B>64, </B>518
&#150;524<!-- HIGHWIRE ID="1:4:293:41" --><!-- /HIGHWIRE --><P><A NAME="R42"><!-- null --></A>
<LI VALUE=42> Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A.
(1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>87, </B>1620
&#150;1624<!-- HIGHWIRE ID="1:4:293:42" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=87/4/1620" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R43"><!-- null --></A>
<LI VALUE=43> Geyer, O., Almog, J., Lupu-Meiri, M., Lazar, M., and Oron, Y.
(1995) Nitric-oxide synthase inhibitors protect rat retina against ischemic injury.
<I>FEBS Lett.</I>
<B>374, </B>399
&#150;402<!-- HIGHWIRE ID="1:4:293:43" --><A HREF="/cgi/external_ref?access_num=10.1016/0014-5793(95)01147-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=7589579&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R44"><!-- null --></A>
<LI VALUE=44> Neufeld, A. H., Sawada, A., and Becker, B.
(1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>96, </B>9944
&#150;9948<!-- HIGHWIRE ID="1:4:293:44" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=96/17/9944" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P></OL>


		
        
        
	
	
	
	
	





 






<BR CLEAR=ALL>




  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>



<A NAME="otherarticles"><!-- null --></A>

<P>
</body></html>